Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.02Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: 46.58%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call highlights strong financial performance with significant revenue growth, successful debt reduction, and progress in clinical programs. However, challenges remain with market uncertainty due to delayed LCD implementation and competitive pressures. Despite these challenges, the company's strategic initiatives and financial health position it well for future opportunities.Company Guidance
During the fourth quarter and fiscal year 2024 earnings call for Organogenesis Holdings, Inc., the company reported robust financial metrics. Fourth-quarter revenue grew 27% year-over-year, reaching $126.7 million, surpassing previous guidance of $100 million to $125 million. Gross profit was $96 million, marking a gross margin of 75.5%, up from 72.1% the previous year. Operating income improved to $10.2 million from a loss of $1.3 million, and GAAP net income rose to $7.7 million from a loss of $0.6 million the prior year. Adjusted EBITDA for the quarter was $18.2 million, or 14.4% of net revenue, exceeding guidance by over $2 million. For fiscal year 2025, Organogenesis provided guidance with expected net revenue between $480 million and $535 million, reflecting a potential year-over-year change from flat to an 11% increase. The guidance also included expectations for GAAP net income between $9.5 million and $38.8 million, and adjusted EBITDA ranging from $43.6 million to $83.2 million, with a focus on leveraging their strong brand equity and commercial infrastructure in a dynamic market environment.Strong Revenue Growth in Q4
Organogenesis delivered sales results above the high end of the guidance range, growing 27% in the fourth quarter of fiscal year 2024.
Advanced Wound Care Performance
Advanced Wound Care net revenue for the fourth quarter was $119 million, up 27% year-over-year.
Improvement in Gross Profit and Operating Income
Gross profit for the fourth quarter was $96 million, or 75.5% of net revenue, compared to 72.1% last year. Operating income for the fourth quarter was $10.2 million compared to an operating loss of $1.3 million last year.
Successful Funding and Debt Reduction
The private placement of Series A convertible preferred stock provided $122.7 million, which was used to pay off $66.6 million in long-term debt.
ReNu Program Progress
Completed enrollment in the second Phase 3 clinical trial for ReNu with expectations for a BLA submission by the end of 2025.
---
ORGO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ORGO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $3.07 | $6.21 | +102.28% |
| Nov 12, 2024 | $3.45 | $4.43 | +28.41% |
| Aug 08, 2024 | $2.62 | $2.55 | -2.67% |
| May 09, 2024 | $2.28 | $3.03 | +32.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Organogenesis Holdings Inc (ORGO) report earnings?
Organogenesis Holdings Inc (ORGO) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Organogenesis Holdings Inc (ORGO) earnings time?
Organogenesis Holdings Inc (ORGO) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ORGO EPS forecast?
ORGO EPS forecast for the fiscal quarter 2025 (Q1) is -0.04.
---